Oncoscience GmbH develops therapeutic options for rare diseases in oncology.
Cancer is one of the leading causes of death worldwide and e.g. in Germany the second leading cause of death after cardiovascular diseases.
Oncoscience GmbH announced today that it has entered into an exclusive supply and distribution agreement with ...
New publication shows benefit in patients with locally advanced or metastatic pancreatic cancer treated with nimotuzumab...
We are now Oncoscience GmbH. Managing directors are Dr. Dirk Reuter, Dr. Budhi Simon and Robert Ellerson....